Dr. Brenden Scott Ingraham, MD

Dr. Ingraham practices at Mayo Clinic Hospital, Saint Marys Campus in Rochester, Minnesota, part of Mayo Clinic.

Dr. Ingraham's NPI, 1497284616, was assigned on June 9, 2017. Dr. Ingraham graduated from University of Alabama School of Medicine in 2017. Dr. Ingraham holds Minnesota license 64105.

Dr. Ingraham's primary practice is Mayo Clinic Hospital, Saint Marys Campus, at 1216 Second Street Southwest, Rochester, MN 55902 in Olmsted County. The practice phone is (507) 255-5123.

Dr. Ingraham's primary practice is Mayo Clinic Hospital, Saint Marys Campus in Rochester, Minnesota, part of Mayo Clinic. The medical group on file is Mayo Clinic. Dmand AI also links Dr. Ingraham to 1 more hospice, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Ingraham practices, 2 sites in all. Vendor and product names are available with a free account.

Cardiovascular disease is Dr. Ingraham's primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Dr. Ingraham is licensed in Minnesota.

CMS data shows 98 Medicare services from Dr. Ingraham across 3 procedure codes in 2024, for 93 Medicare patients. Medicare paid $8,822 for them.

CMS counts 93 Medicare patients who saw Dr. Ingraham in 2024. The largest group is 65 to 74, with 39 patients. 75% of them have high blood pressure, and 75% have high cholesterol. Their average risk score is 1.82, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Ingraham's median patient age at 73, with 39% women.

In 2024, Dr. Ingraham wrote 347 Medicare Part D claims for 80 patients. 92% of them were for generic drugs. CMS names the drug for 248 of them, across 11 drugs with 11 or more claims each, at $3,933 in total drug cost. In 2023, CMS named 216 claims across 10 drugs.

Dr. Ingraham accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 50 procedures of coronary angioplasty and stenting by Dr. Ingraham, more than 84% of the clinicians it reports for that procedure.

Varicose vein removal: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 15 papers to Dr. Ingraham, published from 2019 to 2025. 2019 was the busiest year, with 2. The most frequent topics are Cardiac Catheterization, Platelet Aggregation Inhibitors and Heart Valve Prosthesis Implantation. Dr. Ingraham has published most often in Mayo Clin Proc. Dr. Ingraham's most frequent co-authors are Charanjit S. Rihal, MD, Mackram F. Eleid, MD and Rajiv Gulati, MD.

CMS Open Payments shows 43 general payments to Dr. Ingraham from 11 drug and device companies from 2022 to 2025. Food and beverage make up the largest share, 52% of the total. Inari Medical, Inc. paid the most, $2,126.

Dr. Ingraham graduated from University of Alabama School of Medicine in 2017.